ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents3,844,0009,407,00018,620,0005,001,000
Short Term Investments242,000203,000155,0001,124,000
Net Receivables5,182,0005,249,0003,248,0003,418,000
Inventory3,796,0003,601,0002,434,0002,599,000
Other Current Assets123,000158,000789,000284,000
Total Current Assets14,632,00020,147,00026,776,00014,155,000
Long Term Investments590,000520,0002,955,0004,157,000
Property, plant and equipment7,563,0007,607,0005,705,0005,730,000
Goodwill23,254,00024,020,0007,683,0009,638,000
Intangible Assets18,942,00021,473,0004,539,0005,562,000
Accumulated Amortization----
Other Assets2,192,0002,483,0005,008,0002,005,000
Deferred Long Term Asset Charges1,868,0001,944,0002,255,0002,003,000
Total Assets67,173,00076,250,00052,666,00041,247,000
Current Liabilities
Accounts Payable2,975,0002,402,0001,178,0001,081,000
Short/Current Long Term Debt7,000508,000457,000442,000
Other Current Liabilities868,000798,000824,0001,186,000
Total Current Liabilities9,012,0008,912,0006,660,0009,186,000
Long Term Debt19,359,00027,210,00020,681,0005,871,000
Other Liabilities8,080,0009,030,0004,608,0004,864,000
Deferred Long Term Liability Charges----
Minority Interest198,000201,000179,000115,000
Negative Goodwill----
Total Liabilities36,451,00045,152,00031,949,00019,921,000
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock23,512,00023,206,00013,027,00012,734,000
Retained Earnings24,560,00023,978,00025,565,00025,757,000
Treasury Stock-17,548,000-16,287,000-18,054,000-17,280,000
Capital Surplus----
Other Stockholder Equity-7,586,000-6,062,000-7,263,000-6,658,000
Total stockholders' equity30,524,00030,897,00020,538,00021,211,000
Net Tangible Assets-11,672,000-14,596,0008,316,0006,011,000